Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Knapstein

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcomeH Hawighorst, W Weikel, P G Knapstein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz UniversityE Steiner, O Eicher, J Sagemüller, et al.
Der Radiologe|August 13, 1998
[MRI imaging of the uterine arterial blood flow in normal and malignant uterine tissue by means of 2d-multiphase tagging technic]H Hawighorst, M Bock, M V Knopp, et al.
Magnetic Resonance Imaging|June 11, 1998
Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiencesH Hawighorst, M Bock, M V Knopp, et al.
AJR. American Journal of Roentgenology|February 1, 1996
Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditionsH Hawighorst, P G Knapstein, U Schaeffer, et al.
Cancer Research|July 9, 1999
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancerJ G Hengstler, J Lange, A Kett, et al.
Gynecologic Oncology|April 1, 1997
Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancerB Tanner, J G Hengstler, B Dietrich, et al.
International Journal of Cancer|March 10, 2001
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosisJ G Hengstler, H Pilch, M Schmidt, et al.
Der Radiologe|February 1, 1997
[Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings]H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Research|August 29, 1998
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survivalH Hawighorst, P G Knapstein, M V Knopp, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcomeH Hawighorst, W Weikel, P G Knapstein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz UniversityE Steiner, O Eicher, J Sagemüller, et al.
Der Radiologe|August 13, 1998
[MRI imaging of the uterine arterial blood flow in normal and malignant uterine tissue by means of 2d-multiphase tagging technic]H Hawighorst, M Bock, M V Knopp, et al.
Magnetic Resonance Imaging|June 11, 1998
Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiencesH Hawighorst, M Bock, M V Knopp, et al.
AJR. American Journal of Roentgenology|February 1, 1996
Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditionsH Hawighorst, P G Knapstein, U Schaeffer, et al.
Cancer Research|July 9, 1999
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancerJ G Hengstler, J Lange, A Kett, et al.
Gynecologic Oncology|April 1, 1997
Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancerB Tanner, J G Hengstler, B Dietrich, et al.
International Journal of Cancer|March 10, 2001
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosisJ G Hengstler, H Pilch, M Schmidt, et al.
Der Radiologe|February 1, 1997
[Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings]H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Research|August 29, 1998
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survivalH Hawighorst, P G Knapstein, M V Knopp, et al.
Pageof 10